Eosinophilic gastrointestinal diseases-clinically diverse and histopathologically confounding

Seminars in Immunopathology

Volumn 34, Issue 5, 2012, Pages 715-731

  Aceves, Seema ^a,b   Hirano, Ikuo ^c   Furuta, Glenn T ^d   Collins, Margaret H ^e,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Eosinophilic esophagitis; Esophagitis; Gastrointestinal allergy

Indexed keywords

BUDESONIDE; CICLESONIDE; CORTICOSTEROID; FLUTICASONE; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 13 ANTIBODY; INTERLEUKIN 5 ANTIBODY; MEPOLIZUMAB; PLACEBO; PROTON PUMP INHIBITOR;

ABSCESS; CELL ACTIVITY; CLINICAL ASSESSMENT; DEGRANULATION; DIET RESTRICTION; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EOSINOPHIL; EOSINOPHILIA; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILIC GASTROINTESTINAL DISORDER; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS MUCOSA; EX VIVO STUDY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MUCOSA; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; IMAGE ANALYSIS; IMMUNOHISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; LABORATORY TEST; LOW DRUG DOSE; PRIORITY JOURNAL; REVIEW; STEROID THERAPY; SYMPTOMATOLOGY; TREATMENT DURATION;

ABSCESS; ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; ANIMALS; CELL DEGRANULATION; ENTERITIS; EOSINOPHILIA; GASTRITIS; HUMANS; INFLAMMATION;

EID: 84866137137     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-012-0324-x     Document Type: Review

References (145)

1. Attwood S, Smyrk T, Demeester T, Jones J (1993) Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci 38:109-116
2. Straumann A, Spichtin HP, Bernoulli R, Loosli J, Vogtlin J (1994) Idiopathic eosinophilic esophagitis: A frequently overlooked disease with typical clinical aspects and discrete endoscopic findings. Schweiz Med Wochenschr 124:1419-1429
3. Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, Putnam PE, Bonis P, Hassall E, Straumann A, Rothenberg ME (2007) Eosinophilic esophagitis in children and adults: A systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 133:1342-1363
4. Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, Burks AW, Chehade M, Collins MH, Dellon ES, Dohil R, Falk GW, Gonsalves N, Gupta SK, Katzka DA, Lucendo AJ, Markowitz JE, Noel RJ, Odze RD, Putnam PE, Richter JE, Romero Y, Ruchelli E, Sampson HA, Schoepfer A, Shaheen NJ, Sicherer SH, Spechler S, Spergel JM, Straumann A, Wershil BK, Rothenberg ME, Aceves SS (2011) Eosinophilic esophagitis: Updated consensus recommendations for children and adults. J Allergy Clin Immunol 128(3-20):e6
5. Fleischer DM, Atkins D (2009) Evaluation of the patient with suspected eosinophilic gastrointestinal disease. Immunol Allergy Clin North Am 29:53-63, ix
6. DeBrosse CW, Case JW, Putnam PE, Collins MH, Rothenberg ME (2006) Quantity and distribution of eosinophils in the gastrointestinal tract of children. Pediatr Dev Pathol 9:210-218
7. Lowichik A, Weinberg A (1996) A quantitative evaluation of mucosal eosinophils in the pediatric gastrointestinal tract. Mod Pathol 9
8. Shamri R, Melo RC, Young KM, Bivas-Benita M, Xenakis JJ, Spencer LA, Weller PF (2012) CCL11 elicits secretion of RNases from mouse eosinophils and their cell-free granules. FASEB J 26:2084-2093
9. Collins MH (2009) Histopathology associated with eosinophilic gastrointestinal diseases. Immunol Allergy Clin North Am 29:109-117, x-xi
10. Cheung KM, Oliver MR, Cameron DJ, Catto-Smith AG, Chow CW (2003) Esophageal eosinophilia in children with dysphagia. J Pediatr Gastroenterol Nutr 37:498-503
11. Parfitt JR, Gregor JC, Suskin NG, Jawa HA, Driman DK (2006) Eosinophilic esophagitis in adults: Distinguishing features from gastroesophageal reflux disease: A study of 41 patients. Mod Pathol 19:90-96
12. Collins MH (2008) Histopathologic features of eosinophilic esophagitis. Gastrointest Endosc Clin N Am 18:59, viii-ix
13. Muller S, Puhl S, Vieth M, Stolte M (2007) Analysis of symptoms and endoscopic findings in 117 patients with histological diagnoses of eosinophilic esophagitis. Endoscopy 39:339-344
14. Walsh S, Antonioli D, Goldman H, Fox V, Bousvaros A, Leichtner A, Furuta G (1999) Allergic esophagitis in children -A clinicopathological entity. Am J Surg Pathol 23:390-396
15. Protheroe C, Woodruff SA, de Petris G, Mukkada V, Ochkur SI, Janarthanan S, Lewis JC, Pasha S, Lunsford T, Harris L, Sharma VK, McGarry MP, Lee NA, Furuta GT, Lee JJ (2009) A novel histologic scoring system to evaluate mucosal biopsies from patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 7(749-55):e11
16. Fuentebella J, Patel A, Nguyen T, Sanjanwala B, Berquist W, Kerner JA, Bass D, Cox K, Hurwitz M, Huang J, Nguyen C, Quiros JA, Nadeau K (2010) Increased number of regulatory T cells in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 51:283-289
17. Konikoff MR, Noel RJ, Blanchard C, Kirby C, Jameson SC, Buckmeier BK, Akers R, Cohen MB, Collins MH, Assa'ad AH, Aceves SS, Putnam PE, Rothenberg ME (2006) A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 131:1381-1391
18. Lucendo AJ, De Rezende L, Comas C, Caballero T, Bellon T (2008) Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis. Am J Gastroenterol 103:2184-2193
19. Noel RJ, Putnam PE, Collins MH, Assa'ad AH, Guajardo JR, Jameson SC, Rothenberg ME (2004) Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol 2:568-575
20. Straumann A, Bauer M, Fischer B, Blaser K, Simon HU (2001) Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol 108:954-961
21. Tantibhaedhyangkul U, Tatevian N, Gilger MA, Major AM, Davis CM (2009) Increased esophageal regulatory T cells and eosinophil characteristics in children with eosinophilic esophagitis and gastroesophageal reflux disease. Ann Clin Lab Sci 39:99-107
22. Teitelbaum J, Fox V, Twarog F, Nurko S, Antonioli D, Gleich G, Badezagean K, Furuta G (2002) Eosinophilic esophagitis in children: Immunopathological analysis and response to fluticasone propionate. Gastroenterology 122:1216-1225
23. Stuck MC, Straumann A, Simon HU (2011) Relative lack of T regulatory cells in adult eosinophilic esophagitis -no normalization after corticosteroid therapy. Allergy 66:705-707
24. Lucendo AJ, Navarro M, Comas C, Pascual JM, Burgos E, Santamaria L, Larrauri J (2007) Immunophenotypic characterization and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology: An analysis of the cellular mechanisms of the disease and the immunologic capacity of the esophagus. Am J Surg Pathol 31:598-606
25. Vicario M, Blanchard C, Stringer KF, Collins MH, Mingler MK, Ahrens A, Putnam PE, Abonia JP, Santos J, Rothenberg ME (2010) Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis. Gut 59:12-20
26. Abonia JP, Blanchard C, Butz BB, Rainey HF, Collins MH, Stringer K, Putnam PE, Rothenberg ME (2010) Involvement of mast cells in eosinophilic esophagitis. J Allergy Clin Immunol 126:140-149
27. Aceves SS, Chen D, Newbury RO, Dohil R, Bastian JF, Broide DH (2010) Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-beta1, and increase esophageal smooth muscle contraction. J Allergy Clin Immunol 126(1198-204):e4
28. Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, Jameson SC, Kirby C, Konikoff MR, Collins MH, Cohen MB, Akers R, Hogan SP, Assa'ad AH, Putnam PE, Aronow BJ, Rothenberg ME (2006) Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 116:536-547
29. Chehade M, Sampson HA, Morotti RA, Magid MS (2007) Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 45:319-328
30. Kirsch R, Bokhary R, Marcon MA, Cutz E (2007) Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 44:20-26
31. Mueller S, Aigner T, Neureiter D, Stolte M (2006) Eosinophil infiltration and degranulation in oesophageal mucosa from adult patients with eosinophilic oesophagitis: A retrospective and comparative study on pathological biopsy. J Clin Pathol 59:1175-1180
32. Kagalwalla AF, Akhtar N, Woodruff SA, Rea BA, Masterson JC, Mukkada V, Parashette KR, Du J, Fillon S, Protheroe CA, Lee JJ, Amsden K, Melin-Aldana H, Capocelli KE, Furuta GT, Ackerman SJ (2012) Eosinophilic esophagitis: Epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment. J Allergy Clin Immunol 129:1387-1396
33. Lucendo AJ, Arias A, Perez-Martinez I, Lopez-Vazquez A, Ontanon-Rodriguez J, Gonzalez-Castillo S, De Rezende LC, Rodrigo L (2011) Adult patients with eosinophilic esophagitis do not show an increased frequency of the HLA-DQ2/DQ8 genotypes predisposing to celiac disease. Dig Dis Sci 56:1107-1111
34. Straumann A, Spichtin HP, Grize L, Bucher KA, Beglinger C, Simon HU (2003) Natural history of primary eosinophilic esophagitis: A follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 125:1660-1669
35. Aceves SS, Newbury RO, Chen D, Mueller J, Dohil R, Hoffman H, Bastian JF, Broide DH (2010) Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy 65:109-116
36. Aceves SS, Newbury RO, Dohil R, Bastian JF, Broide DH (2007) Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol 119:206-212
37. Blanchard C, Mingler MK, McBride M, Putnam PE, Collins MH, Chang G, Stringer K, Abonia JP, Molkentin JD, Rothenberg ME (2008) Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses. Mucosal Immunol 1:289-296
38. Dohil R, Newbury RO, Aceves S (2012) Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis. Dig Dis Sci 57:1413-1419
39. Molina-Infante J, Ferrando-Lamana L, Fernandez-Bermejo M, Porcel-Carreno S (2009) Eosinophilic esophagitis in GERD patients: A clinicopathological diagnosis using proton pump inhibitors. Am J Gastroenterol 104:2856-2857
40. Molina-Infante J, Ferrando-Lamana L, Ripoll C, Hernandez-Alonso M, Mateos JM, Fernandez-Bermejo M, Duenas C, Fernandez-Gonzalez N, Quintana EM, Gonzalez-Nunez MA (2010) Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol 9:110-117
41. Molina-Infante J, Zamorano J (2012) Distinguishing eosinophilic esophagitis from gastroesophageal reflux disease upon PPI refractoriness: What about PPI-responsive esophageal eosinophilia? Digestion 85:210
42. Gonsalves N, Policarpio-Nicolas M, Zhang Q, Rao MS, Hirano I (2006) Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc 64:313-319
43. Shah A, Kagalwalla AF, Gonsalves N, Melin-Aldana H, Li BU, Hirano I (2009) Histopathologic variability in children with eosinophilic esophagitis. Am J Gastroenterol 104:716-721
44. Abe Y, Iijima K, Ohara S, Koike T, Ara N, Uno K, Asano N, Imatani A, Kato K, Shibuya D, Shimosegawa T (2011) A Japanese case series of 12 patients with esophageal eosinophilia. J Gastroenterol 46:25-30
45. Bakirtas A, Arga M, Egritas O, Topal E, Sari S, Poyraz A, Dalgic B, Demirsoy MS, Turktas I (2012) The first experience of eosinophilic esophagitis in Turkish children. Turk J Gastroenterol 23:1-7
46. Dalby K, Nielsen RG, Kruse-Andersen S, Fenger C, Bindslev-Jensen C, Ljungberg S, Larsen K, Walsted AM, Husby S (2010) Eosinophilic oesophagitis in infants and children in the region of Southern Denmark: A prospective study of prevalence and clinical presentation. J Pediatr Gastroenterol Nutr 51:280-282
47. Joo MK, Park JJ, Kim SH, Kim KH, Jung W, Yun JW, Lee BJ, Kim JH, Yeon JE, Kim JS, Byun KS, Lee SW, Bak YT (2012) Prevalence and endoscopic features of eosinophilic esophagitis in patients with esophageal or upper gastrointestinal symptoms. J Dig Dis 13:296-303
48. Kalach N, Huvenne H, Gosset P, Papadopoulos S, Dehecq E, Decoster A, Creusy C, Dupont C (2011) Eosinophil counts in upper digestive mucosa of Western European children: Variations with age, organs, symptoms, Helicobacter pylori status, and pathological findings. J Pediatr Gastroenterol Nutr 52:175-182
49. Shi YN, Sun SJ, Xiong LS, Cao QH, Cui Y, Chen MH (2012) Prevalence, clinical manifestations and endoscopic features of eosinophilic esophagitis: A pathological review in China. J Dig Dis 13:304-309
50. Vindigni C, Villanacci V, Marini M, Rocca BJ, Frosini G, Pedruzzi E, Corazzi N, Bassotti G, Tosi P (2010) Eosinophilic esophagitis: An Italian experience. Rev Esp Enferm Dig 102:15-19
51. Noel RJ, Putnam PE, Rothenberg ME (2004) Eosinophilic esophagitis. N Engl J Med 351:940-941
52. Straumann A, Aceves SS, Blanchard C, Collins MH, Furuta GT, Hirano I, Schoepfer AM, Simon D, Simon HU (2012) Pediatric and adult eosinophilic esophagitis: Similarities and differences. Allergy 67:477-490
53. Cello JP (1979) Eosinophilic gastroenteritis -A complex disease entity. Am J Med 67:1097-1104
54. Rothenberg ME (2004) Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 113:11-28, quiz 9
55. Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR (1990) Eosinophilic gastroenteritis: A clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut 31:54-58
56. Chang JY, Choung RS, Lee RM, Locke GR 3rd, Schleck CD, Zinsmeister AR, Smyrk TC, Talley NJ (2010) A shift in the clinical spectrum of eosinophilic gastroenteritis toward the mucosal disease type. Clin Gastroenterol Hepatol 8:669-675, quiz e88
57. Putnam PE (2008) Eosinophilic esophagitis in children: Clinical manifestations. Gastroenterol Clin North Am 37:369-381
58. Mukkada VA, Haas A, Maune NC, Capocelli KE, Henry M, Gilman N, Petersburg S, Moore W, Lovell MA, Fleischer DM, Furuta GT, Atkins D (2010) Feeding dysfunction in children with eosinophilic gastrointestinal diseases. Pediatrics 126:e672-e677
59. Pentiuk SP, Miller CK, Kaul A (2007) Eosinophilic esophagitis in infants and toddlers. Dysphagia 22:44-48
60. Taft TH, Kern E, Keefer L, Burstein D, Hirano I (2011) Qualitative assessment of patient-reported outcomes in adults with eosinophilic esophagitis. J Clin Gastroenterol 45:769-774
61. Desai TK, Stecevic V, Chang CH, Goldstein NS, Badizadegan K, Furuta GT (2005) Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc 61:795-801
62. Hurtado CW, Furuta GT, Kramer RE (2011) Etiology of esophageal food impactions in children. J Pediatr Gastroenterol Nutr 52:43-46
63. Prasad GA, Talley NJ, Romero Y, Arora AS, Kryzer LA, Smyrk TC, Alexander JA (2007) Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: A prospective study. Am J Gastroenterol 106:851-857
64. Straumann A, Bussmann C, Zuber M, Vannini S, Simon HU, Schoepfer A (2008) Eosinophilic esophagitis: Analysis of food impaction and perforation in 251 adolescent and adult patients. Clin Gastroenterol Hepatol 6:598-600
65. Hogan SP, Rothenberg ME (2006) Eosinophil function in eosinophil-associated gastrointestinal disorders. Curr Allergy Asthma Rep 6:65-71
66. Debrosse CW, Rothenberg ME (2008) Allergy and eosinophilassociated gastrointestinal disorders (EGID). Curr Opin Immunol 20:703-708
67. Pentiuk S, Putnam PE, Collins MH, Rothenberg ME (2009) Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 48:152-160
68. Alexander JA, Jung KW, Arora AS, Enders F, Katzka DA, Kephardt GM, Kita H, Kryzer LA, Romero Y, Smyrk TC, Talley NJ (2012) Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol in press
69. Assa'ad AH, Gupta SK, Collins MH, Thomson M, Heath AT, Smith DA, Perschy TL, Jurgensen CH, Ortega HG, Aceves SS (2011) An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology 141:1593-1604
70. Peterson KA, Thomas KL, Hilden K, Emerson LL, Wills JC, Fang JC (2010) Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci 55:1313-1319
71. Spergel JM, Rothenberg ME, Collins MH, Furuta GT, Markowitz JE, Fuchs G 3rd, O'Gorman MA, Abonia JP, Young J, Henkel T, Wilkins HJ, Liacouras CA (2012) Reslizumab in children and adolescents with eosinophilic esophagitis: Results of a doubleblind, randomized, placebo-controlled trial. J Allergy Clin Immunol 129:456-463, 63 e1-3
72. Aceves SS, Newbury RO, Dohil MA, Bastian JF, Dohil R (2009) A symptom scoring tool for identifying pediatric patients with eosinophilic esophagitis and correlating symptoms with inflammation. Ann Allergy Asthma Immunol 103:401-406
73. Dohil R, Newbury R, Fox L, Bastian J, Aceves S (2010) Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology 139:418-429
74. Straumann A, Conus S, Degen L, Felder S, Kummer M, Engel H, Bussmann C, Beglinger C, Schoepfer A, Simon HU (2010) Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology 139:1526-1537, 37 e1
75. Arora AS, Perrault J, Smyrk TC (2003) Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults. Mayo Clin Proc 78:830-835
76. Faubion WA Jr, Perrault J, Burgart LJ, Zein NN, Clawson M, Freese DK (1998) Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr 27:90-93
77. Liacouras CA, Wenner W, Brown K, Ruchelli E (1998) Primary eosinophilic esophagitis in children: Successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr 26:380-385
78. Markowitz JE, Spergel JM, Ruchelli E, Liacouras CA (2003) Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol 98:777-782
79. Schaefer ET, Fitzgerald JF, Molleston JP, Croffie JM, Pfefferkorn MD, Corkins MR, Lim JD, Steiner SJ, Gupta SK (2008) Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: A randomized trial in children. Clin Gastroenterol Hepatol 6:165-173
80. Aceves SS (2011) Tissue remodeling in patients with eosinophilic esophagitis: What lies beneath the surface? J Allergy Clin Immunol 128:1047-1049
81. Aceves SS, Ackerman SJ (2009) Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis. Immunol Allergy Clin North Am 29:197-211, xiii-xiv
82. Straumann A (2008) The natural history and complications of eosinophilic esophagitis. Gastrointest Endosc Clin N Am 18:99-118, ix
83. Lee J, Huprich J, Kujath C, Ravi K, Enders F, Smyrk TC, Katzka DA, Talley NJ, Alexander JA (2012) Esophageal diameter is decreased in some patients with eosinophilic esophagitis and might increase with topical corticosteroid therapy. Clin Gastroenterol Hepatol 10:481-486
84. Kwiatek MA, Hirano I, Kahrilas PJ, Rothe J, Luger D, Pandolfino JE (2011) Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology 140:82-90
85. Hirano I, Moy N, Heckman MG, Thomas CS, Gonsalves N, Achem SR (2012) Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: Validation of a novel classification and grading system. Gut
86. Straumann A, Spichtin HP, Bucher KA, Heer P, Simon HU (2004) Eosinophilic esophagitis: Red on microscopy, white on endoscopy. Digestion 70:109-116
87. Sundaram S, Sunku B, Nelson SP, Sentongo T, Melin-Aldana H, Kumar R, Li BU (2004) Adherent white plaques: An endoscopic finding in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 38:208-212
88. Kim HP, Vance RB, Shaheen NJ, Dellon ES (2012) The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: A meta-analysis. Clin Gastroenterol Hepatol (in press)
89. Feczko P, Halpert R, ZoncaM (1985) Radiographic abnormalities in eosinophilic esophagitis. Gastrointest Radiol 10:321-324
90. Landres RT, Kuster GG, Strum WB (1978) Eosinophilic esophagitis in a patient with vigorous achalasia. Gastroenterology 74:1298-1301
91. Picus D, Frank PH (1981) Eosinophilic esophagitis. AJR Am J Roentgenol 136:1001-1003
92. Nurko S, Rosen R (2008) Esophageal dysmotility in patients who have eosinophilic esophagitis. Gastrointest Endosc Clin N Am 18:73-89, ix
93. Nurko S, Rosen R, Furuta GT (2009) Esophageal dysmotility in children with eosinophilic esophagitis: A study using prolonged esophageal manometry. Am J Gastroenterol 104:3050-3057
94. Roman S, Hirano I, Kwiatek MA, Gonsalves N, Chen J, Kahrilas PJ, Pandolfino JE (2011) Manometric features of eosinophilic esophagitis in esophageal pressure topography. Neurogastroenterol Motil 23(208-14):e111
95. Korsapati H, Babaei A, Bhargava V, Dohil R, Quin A, Mittal RK (2009) Dysfunction of the longitudinal muscles of the oesophagus in eosinophilic oesophagitis. Gut 58:1056-1062
96. Flavahan NA, Slifman NR, Gleich GJ, Vanhoutte PM (1988) Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium. Am Rev Respir Dis 138:685-688
97. Conus S, Straumann A, Simon HU (2009) Anti-IL-5 (mepolizumab) therapy does not alter IL-5 receptor alpha levels in patients with eosinophilic esophagitis. J Allergy Clin Immunol 123:269, author reply -70
98. Fox VL, Nurko S, Teitelbaum JE, Badizadegan K, Furuta GT (2003) High-resolution EUS in children with eosinophilic "allergic" esophagitis. Gastrointest Endosc 57:30-36
99. Schoepfer AM, Gonsalves N, Bussmann C, Conus S, Simon HU, Straumann A, Hirano I (2010) Esophageal dilation in eosinophilic esophagitis: Effectiveness, safety, and impact on the underlying inflammation. Am J Gastroenterol 105:1062-1070
100. Assa'ad AH, Putnam PE, Collins MH, Akers RM, Jameson SC, Kirby CL, Buckmeier BK, Bullock JZ, Collier AR, Konikoff MR, Noel RJ, Guajardo JR, Rothenberg ME (2007) Pediatric patients with eosinophilic esophagitis: An 8-year follow-up. J Allergy Clin Immunol 119:731-738
101. Straumann A, Conus S, Degen L, Frei C, Bussmann C, Beglinger C, Schoepfer A, Simon HU (2011) Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 9:400-409
102. Helou EF, Simonson J, Arora AS (2008) 3-yr-follow-up of topical corticosteroid treatment for eosinophilic esophagitis in adults. Am J Gastroenterol 103:2194-2199
103. Allen KJ, Heine RG (2011) Eosinophilic esophagitis: Trials and tribulations. J Clin Gastroenterol 45:574-582
104. Hirano I (2012) Therapeutic end points in eosinophilic esophagitis: Is elimination of esophageal eosinophils enough? Clin Gastroenterol Hepatol 10(7):750-752
105. Straumann A (2012) Treatment of eosinophilic esophagitis: Diet, drugs, or dilation? Gastroenterology 142:1409-1411
106. Spergel JM, Brown-Whitehorn TF, Beausoleil JL, Franciosi J, Shuker M, Verma R, Liacouras CA (2009) 14 years of eosinophilic esophagitis: Clinical features and prognosis. J Pediatr Gastroenterol Nutr 48:30-36
107. Rothenberg ME (2009) Biology and treatment of eosinophilic esophagitis. Gastroenterology 137:1238-1249
108. Broide DH, Finkelman F, Bochner BS, Rothenberg ME (2011) Advances in mechanisms of asthma, allergy, and immunology in 2010. J Allergy Clin Immunol 127:689-695
109. Sherrill JD, Rothenberg ME (2011) Genetic dissection of eosinophilic esophagitis provides insight into disease pathogenesis and treatment strategies. The Journal of allergy and clinical immunology 128:23-32
110. Caldwell JM, Blanchard C, Collins MH, Putnam PE, Kaul A, Aceves SS, Bouska CA, Rothenberg ME (2010) Glucocorticoidregulated genes in eosinophilic esophagitis: A role for FKBP51. J Allergy Clin Immunol 125(879-88):e8
111. Lu TX, Sherrill JD, Wen T, Plassard AJ, Besse JA, Abonia JP, Franciosi JP, Putnam PE, Eby M, Martin LJ, Aronow BJ, Rothenberg ME (2012)MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers. J Allergy Clin Immunol 129(1064-75):e9
112. Rothenberg ME, Spergel JM, Sherrill JD, Annaiah K, Martin LJ, Cianferoni A, Gober L, Kim C, Glessner J, Frackelton E, Thomas K, Blanchard C, Liacouras C, Verma R, Aceves S, Collins MH, Brown-Whitehorn T, Putnam PE, Franciosi JP, Chiavacci RM, Grant SF, Abonia JP, Sleiman PM, Hakonarson H (2010) Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet 42:289-291
113. Blanchard C, Mingler MK, Vicario M, Abonia JP, Wu YY, Lu TX, Collins MH, Putnam PE, Wells SI, Rothenberg ME (2007) IL-13 involvement in eosinophilic esophagitis: Transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol 120:1292-1300
114. Cheng E, Zhang X, Huo X, Yu C, Zhang Q, Wang DH, Spechler SJ, Souza RF (2012) Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut (in press)
115. Mulder DJ, Pacheco I, Hurlbut DJ, Mak N, Furuta GT, MacLeod RJ, Justinich CJ (2009) FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis. Gut 58:166-173
116. Zuo L, Fulkerson PC, Finkelman FD, Mingler M, Fischetti CA, Blanchard C, Rothenberg ME (2010) IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha2-inhibited pathway. J Immunol 185:660-669
117. Lucendo AJ, Pascual-Turrion JM, Navarro M, Comas C, Castillo P, Letran A, Caballero MT, Larrauri J (2007) Endoscopic, bioptic, and manometric findings in eosinophilic esophagitis before and after steroid therapy: A case series. Endoscopy 39:765-771
118. Safdarian N, Liu Z, Zhou X, Appelman H, Nostrant TT, Wang TD,Wang ET (2012) Quantifying human eosinophils using threedimensional volumetric images collected with multiphoton fluorescence microscopy. Gastroenterology 142(15-20):e1
119. Yoo H, Kang D, Katz AJ, Lauwers GY, Nishioka NS, Yagi Y, Tanpowpong P, Namati J, Bouma BE, Tearney GJ (2011) Reflectance confocal microscopy for the diagnosis of eosinophilic esophagitis: A pilot study conducted on biopsy specimens. Gastrointest Endosc 74:992-1000
120. Mishra A, Hogan SP, Brandt EB, Rothenberg ME (2001) An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest 107:83-90
121. Mishra A, Hogan SP, Brandt EB, Rothenberg ME (2002) IL-5 promotes eosinophil trafficking to the esophagus. J Immunol 168:2464-2469
122. Mishra A, Rothenberg ME (2003) Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology 125:1419-1427
123. Mishra A, Schlotman J, Wang M, Rothenberg ME (2007) Critical role for adaptive T cell immunity in experimental eosinophilic esophagitis in mice. J Leukoc Biol 81:916-924
124. Mishra A, Wang M, Pemmaraju VR, Collins MH, Fulkerson PC, Abonia JP, Blanchard C, Putnam PE, Rothenberg ME (2008) Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology 134:204-214
125. Blanchard C, Stucke EM, Rodriguez-Jimenez B, Burwinkel K, CollinsMH, Ahrens A, Alexander ES, Butz BK, Jameson SC, Kaul A, Franciosi JP, Kushner JP, Putnam PE, Abonia JP, Rothenberg ME (2011) A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J Allergy Clin Immunol 127:208-217, 17 e1-7
126. Stein ML, Collins MH, Villanueva JM, Kushner JP, Putnam PE, Buckmeier BK, Filipovich AH, Assa'ad AH, Rothenberg ME (2006) Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol 118:1312-1319
127. Straumann A, Conus S, Grzonka P, Kita H, Kephart G, Bussmann C, Beglinger C, Smith DA, Patel J, Byrne M, Simon HU (2010) Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: A randomised, placebo-controlled, double-blind trial. Gut 59:21-30
128. Zhu X, Wang M, Mavi P, Rayapudi M, Pandey AK, Kaul A, Putnam PE, Rothenberg ME, Mishra A (2010) Interleukin-15 expression is increased in human eosinophilic esophagitis and mediates pathogenesis in mice. Gastroenterology 139(182-93):e7
129. Rubinstein E, Cho JY, Rosenthal P, Chao J, Miller M, Pham A, Aceves SS, Varki A, Broide DH (2011) Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 53:409-416
130. Mavi P, Rajavelu P, Rayapudi M, Paul RJ, Mishra A (2012) Esophageal functional impairments in experimental eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol 302:G1347-G1355
131. Rajavelu P, Rayapudi M, Moffitt M, Mishra A (2012) Significance of para-esophageal lymph nodes in food or aeroallergeninduced iNKT cell-mediated experimental eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol 302:G645-G654
132. Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Sampson HA (1995) Eosinophilic esophagitis attributed to gastroesophageal reflux: Improvement with an amino acid-based formula. Gastroenterology 109:1503-1512
133. Henderson CJ, Abonia JP, King EC, Putnam PE, Collins MH, Franciosi JP, Rothenberg ME (2012) Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis. J Allergy Clin Immunol 129:1570-1578
134. Spergel JM, Andrews T, Brown-Whitehorn TF, Beausoleil JL, Liacouras CA (2005) Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol 95:336-343
135. Spergel JM, Beausoleil JL, Mascarenhas M, Liacouras CA (2002) The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol 109:363-368
136. Spergel JM, Brown-Whitehorn T, Beausoleil JL, Shuker M, Liacouras CA (2007) Predictive values for skin prick test and atopy patch test for eosinophilic esophagitis. J Allergy Clin Immunol 119:509-511
137. Gonsalves N, Yang GY, Doerfler B, Ritz S, Ditto AM, Hirano I (2012) Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology 142(1451-9):e1
138. Kagalwalla AF, Sentongo TA, Ritz S, Hess T, Nelson SP, Emerick KM, Melin-Aldana H, Li BU (2006) Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol 4:1097-1102
139. Aceves SS, Bastian JF, Newbury RO, Dohil R (2007) Oral viscous budesonide: A potential new therapy for eosinophilic esophagitis in children. Am J Gastroenterol 102:2271-2279
140. Schroeder S, Fleischer DM, Masterson JC, Gelfand E, Furuta GT, Atkins D (2012) Successful treatment of eosinophilic esophagitis with ciclesonide. J Allergy Clin Immunol 129:1419-1421
141. Aceves SS, Dohil R, Newbury RO, Bastian JF (2005) Topical viscous budesonide suspension for treatment of eosinophilic esophagitis. J Allergy Clin Immunol 116:705-706
142. Dellon ES, Sheikh A, Speck O, Woodward K, Whitlow AB, Hores JM, Ivanovic M, Chau A, Woosley JT, Madanick RD, Orlando RC, Shaheen NJ (2012) Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis. Gastroenterology (in press)
143. Souza RF, Huo X, Mittal V, Schuler CM, Carmack SW, Zhang HY, Zhang X, Yu C, Hormi-Carver K, Genta RM, Spechler SJ (2009) Gastroesophageal reflux may cause esophagitis through a cytokine-mediated mechanism, not by caustic (acid) injury. Gastroenterology 137:1776-1784
144. Spechler SJ, Genta RM, Souza RF (2007) Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol 102:1301-1306
145. Foster B, Foroughi S, Yin Y, Prussin C (2011) Effect of anti-IgE therapy on food allergen specific T cell responses in eosinophil associated gastrointestinal disorders. Clin Mol Allergy 9:7